Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator. The study, based on data from the Women's Health Initiative, will be published Wednesday in The New England Journal of Medicine.
More...
Linear Mode
